autogenous vaccines: an inactivated immunological veterinary medicinal product that is manufactured from pathogens and antigens obtained from one or more animals in an epidemiological unit and used for the treatment of such animal(s) in the same epidemiological unit or for the treatment of one or more animals in a unit for which an epidemiological link has been confirmed.
Definition of autovaccine given in: Regulation (EU) 2019/6 of the European Parliament and of the Council of 11 December 2018 on veterinary medicinal products and repealing Directive 2001/82/EC.
specific: made from pathogenic strains obtained from the farm itself after identification and antigenic characterisation according to serotype, virulence factors or genetic sequencing; targeted to the farm itself or epidemiological unit
updated: constantly updated with the incorporation of recent strains according to new diagnoses
combinable: in multifactorial processes, it is necessary to include several pathogens in the same autovaccine
safe: they are inactivated, in no case can they reproduce the disease
indicated when there is no registered veterinary vaccine for that animal species and that antigenic variant or existing vaccines have shown lack of efficacy
for the control by immunoprophylaxis of infectious processes present on farms
must be produced by an approved laboratory (REG Exopol No: 235/50/015-A)
are dispensed on veterinary prescription following confirmatory laboratory diagnosis
